Coral Laboratories Ltd.

Healthcare · Pharmaceuticals & Biotechnology

BSE: 524506
₹568.05
Sept. 30, 2026 · BSE · bse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #118 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

CompanyMarket cap (₹ Cr)PE (TTM)ROE1Y returnDiv. yieldQualityValuationMomentum
Sun Pharmaceutical Industries Limited 435,863 146.5 13.7% 11.0% — 72 8 30
Divi's Laboratories Limited 246,660 83.9 15.3% 62.7% 0.32% 70 4 51
Torrent Pharmaceuticals Limited 162,454 78.2 12.2% 34.6% 0.79% 56 0 31
Zydus Lifesciences Limited 115,910 33.3 17.3% 17.2% 0.09% 74 24 84
Cipla Limited 108,736 35.4 11.2% -11.0% 0.97% 73 29 62
Laurus Labs Limited 106,969 122.5 17.1% 127.1% — 78 24 53
Mankind Pharma Limited 103,406 47.4 11.7% 2.6% — 68 12 86
Dr. Reddy's Laboratories Limited 102,916 154.7 10.9% -0.9% — 62 33 71
Coral Laboratories Ltd. (this stock) 203 10.6 7.8% -28.1% — 63 99 32

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value
₹206 Cr
EV / EBITDA
7.1x
EV / Sales
2.13x
Market cap / Sales
2.10x
Earnings yield
9.46%

Quarterly Financials

↑ Positive
Quarterly Revenue

Jun 2026 quarterly revenue is Rs 32 Cr, up 52.3% YoY.

↑ Positive
Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 5 Cr, up 110.1% YoY.

Period endRevenue (₹ Cr)PBT (₹ Cr)Net profit (₹ Cr)Basic EPS
June 30, 2026 30 7 5 ₹15.0800
March 31, 2026 26 8 5 ₹14.6200
Dec. 31, 2025 22 4 3 ₹7.7700
Sept. 30, 2025 19 7 6 ₹16.2900
June 30, 2025 19 4 3 ₹7.1800
Dec. 31, 2024 23 8 6 ₹17.2000
Sept. 30, 2024 32 9 6 ₹17.8600
June 30, 2024 32 12 9 ₹24.6400
March 31, 2024 29 8 6 ₹16.2000
Dec. 31, 2023 18 3 2 ₹6.0400
Sept. 30, 2023 23 8 6 ₹16.8100
June 30, 2023 14 2 2 ₹5.1600
March 31, 2023 11 -2 -1 ₹-2.5000

Quarterly income statement (standalone, ₹ Cr)

IndicatorJun 26Mar 26Dec 25Sep 25Jun 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23
Total income (before exceptional items)32292422212635333120251513
Operating revenue30262219192332322918231411
Other income2323233221211
Operating expenses242020141717262123——1214
Operating profit5625267116——2-2
Operating profit margin18.5%23.4%8.8%25.9%11.6%27.5%20.2%33.9%21.6%——12.9%-18.2%
Depreciation1110011010011
Interest000000000——00
Exceptional items, gain / (loss)—-0—0————-0-0———
Profit before tax7847489128382-2
Tax231212232121-1
Net profit553636696262-1
EPS15.0814.627.7716.297.1817.2017.8624.6416.206.0416.815.16-2.50
Net profit (TTM)1916172124272323169876
EPS (TTM)53.7645.8648.4458.5366.8875.9064.7463.6944.2125.5121.8718.7618.04

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

IndicatorCAGR 3YCAGR 5YMar 26Mar 24Mar 23Mar 22Mar 21Mar 20Mar 19Mar 18Mar 17
Total income (before exceptional items) 4.1% -0.9% 96†90†85†80†100†76†96†—94†
Operating revenue 3.2% -2.3% 86†84†78†76†97†71†91†93†90†
Other income — — 10†7†7†5†4†6†5†—3†
Operating expenses — — 71†—74†67†81†65†——67†
Operating profit 58.6% -0.8% 15†—4†8†16†5†——23†
Operating profit margin — — 17.7%†—4.9%†10.9%†16.4%†7.5%†——25.6%†
Depreciation — — 2†2†2†2†2†2†2†—2†
Interest — — 0†—0†0†0†0†——0†
Exceptional items, gain / (loss) — — 0†-0†0†1†0†0†0†0†0†
Profit before tax 41.1% 5.6% 23†21†8†12†18†9†16†18†25†
Tax — — 7†5†2†3†4†2†5†6†9†
Net profit 36.5% 3.9% 16†16†6†9†14†7†10†12†16†
EPS 36.5% 3.9% 45.86†44.21†18.04†25.32†37.95†19.96†———

† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

RatioMar 26Mar 24Mar 23Mar 22Mar 21Mar 20Mar 19Mar 18Mar 17
Operating margin17.7%†—4.9%†10.9%†16.4%†7.5%†——25.6%†
EBIT margin27.1%†—11.0%†15.9%†18.3%†13.0%†——27.5%†
PBT margin26.9%†24.8%†10.5%†15.7%†18.2%†12.9%†17.0%†19.4%†27.5%†
Net margin19.1%†18.9%†8.3%†12.0%†14.0%†10.1%†11.2%†13.4%†18.0%†
Interest coverage135.80x†—25.30x†85.03x†415.42x†157.92x†——724.43x†
Dividend payout—————————
Earnings retention—————————
Current ratio6.48x————————
Quick ratio5.73x————————
Debt to equity0.02x————————
Return on equity7.8%†————————
Return on assets6.8%†————————
Return on capital employed10.9%†————————
Asset turnover0.36x†————————

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year endedOperating (₹ Cr)Investing (₹ Cr)Financing (₹ Cr)Capex (₹ Cr)Free Cash Flow (₹ Cr)
March 31, 2026 16 -18 0 21 -5
March 31, 2025 -1 -0 3 3 -4

Balance Sheet (standalone)

Year endedTotal Assets (₹ Cr)Total Equity (₹ Cr)Reserves (₹ Cr)Borrowings, Current (₹ Cr)Borrowings, Non-current (₹ Cr)Current Assets (₹ Cr)Current Liabilities (₹ Cr)Cash & Equivalents (₹ Cr)Net Block (₹ Cr)Inventory (₹ Cr)
March 31, 2026 241 209 206 4 0 177 27 1 43 21
March 31, 2025 229 201 198 4 0 177 25 3 22 10

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.